MedTrace Logo

The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men

NCT02303483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-07-02

No results posted yet for this study

Summary

In animals, treatment with vitamin B3 improved insulin sensitivity and substrate metabolism. It is currently not know if vitamin B3 has the same positive effects in humans. In the current study the effect of a 3 month treatment with vitamin B3 on insulin sensitivity and substrate metabolism in obese men will be investigated.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA )

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Ole Dollerup, MD · The Novo Nordisk Foundation Center for Basic Metabolic Research, Integrative Physiology, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-04
Primary Completion
2017-04-04
Completion
2017-04-04

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303483 on ClinicalTrials.gov